| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8268e39ce70ff2ad19742e2a21d5a90c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24234 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
| filingDate |
2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fc37ed42bb7ce70f2d05799257b9b57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ff6638eb6601ce116bf7ea93b3844eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_623efbaf6a51a82143f99ded4f469e38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26d62997a691cf958488153b0605e89b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ad6130979db39c6e257213059a1978f |
| publicationDate |
2010-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20100014476-A |
| titleOfInvention |
Human antibodies against hepatitis C virus (HCC) and uses thereof |
| abstract |
Disclosed herein are compositions and molecules based on isolated human monoclonal antibodies and related antibodies that bind to hepatitis C virus (HCV). Such human antibodies can be produced in transfectoma or nonhuman transgenic animals (eg, transgenic mice) that can produce multiple isotypes of human monoclonal antibodies by undergoing VDJ recombination and isotype switching. . Also disclosed are pharmaceutical compositions comprising the human antibodies, hybridomas that produce non-human transgenic animals and human antibodies, and methods of treatment and diagnostics using the human antibodies. |
| priorityDate |
2007-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |